The mazEF Sa toxin-antitoxin (TA) system is ubiquitous in clinical isolates of Staphylococcus aureus, yet its physiological role is unclear. MazF Sa is a sequence-specific endoribonuclease that inhibits the growth of S. aureus and Escherichia coli on ectopic overexpression. MazF Sa preferentially cleaves RNA at UACAU sites, which are overrepresented in genes encoding pathogenicity factors. The exploitation of the inherent toxicity of MazF Sa by artificial toxin activation has been proposed as an antibacterial strategy; however, enzymatic activity of endogenous MazF Sa has never been detected, and tools for such analyses are lacking. Here we detail methods for detection of the ribonuclease activity of MazF Sa , including a continuous fluorometric assay and a gel-based cleavage assay. Importantly, these methods allowed for the first detection of endogenous MazF Sa enzymatic activity in S. aureus lysate. These robust and sensitive assays provide a toolkit for the identification, analysis, and validation of stressors that induce MazF enzymatic activity and should assist in the discovery of artificial activators of the mazEF Sa TA system. Ó 2013 Elsevier Inc. All rights reserved.
1 systems were first discovered on plasmids, where they serve as plasmid maintenance systems via a post-segregational killing (PSK) mechanism [1] [2] [3] . In the canonical type II TA system, plasmid maintenance ensures continued production of the co-expressed inactive complex of antitoxin and toxin; however, if the plasmid is not inherited by a daughter cell, the labile antitoxin succumbs to degradation by the Lon or Clp proteases, releasing the toxin to kill the cell [4] [5] [6] [7] . TA systems are also encoded on the chromosomes of nearly all free-living bacteria [8] , although here their precise role remains a topic of much debate [9, 10] . As observed for multiple different TA systems, rapid bacterial cell death is induced by the free toxin; these results have led to speculation that artificial activation of toxin proteins from TA systems could be a powerful antibacterial strategy [11] [12] [13] [14] [15] [16] .
In one study, the mazEF Sa TA genes were detected in 100% (78 of 78) clinical isolates of MRSA (methicillin-resistant Staphylococcus aureus), and the mazEF Sa transcript was also detected in these isolates [17] . Ectopic overexpression of MazF Sa in S. aureus decreased cell viability by 2-log colony-forming units (CFU)/ml after 60 min of induction [18] ; however, there was only approximately 27% difference in cell death at the 60-min time point, suggesting that MazF Sa induces stasis and not cell death [18] . MazF Sa is a sequence-specific endoribonuclease that cleaves at U;ACAU [19] . This sequence is highly abundant in certain transcripts, including those that code for virulence factors such as the serine-rich pathogen adhesion factor SraP [19] . Overexpression of MazF Sa in S. aureus results in time-dependent cleavage of other virulence transcripts, including hla and spa, whereas the essential housekeeping transcripts recA and gyrB were not cleaved [20] . Thus, the activation of MazF Sa could serve as an anti-virulence strategy by enhancing its ability to cleave virulence factor encoding transcripts. However, the cellular role of MazF Sa remains unclear, and the larger question about the cellular role of chromosomally encoded TA systems has not been answered. In fact, although a number of studies have examined the mazEF Sa gene cluster (via polymerase chain reaction [PCR] ) [17] , the inducibility of the maz-EF Sa transcript with various stressors (via Northern blots and reverse transcription [RT]-PCR) [18, 21] , and the presence of the proteins (via Western blot) [22] , there have been no studies that assess the enzymatic activity of MazF Sa in its cellular context, and tools for such evaluations are lacking. Ultimately, the ribonuclease activity of MazF Sa will dictate its ability to restrict growth or kill the cell, and non-enzymatic assessments (e.g., DNA, RNA, or protein levels) are only surrogates that do not directly report on actual enzyme activity. Further complicating matters is the fact that the transcripts for MazE Sa and MazF Sa are typically co-produced [18, 21] ; thus, elevation at the messenger RNA (mRNA) or protein level does not necessitate heightened MazF Sa enzymatic activity because levels of the MazE Sa antitoxin are also raised.
As described here, using a fluorogenic substrate, we have determined the kinetic parameters for MazF Sa . In addition, an mRNA transcript was engineered to contain one optimal MazF Sa cleavage sequence, and this substrate provides a means for clear and rapid assessment of MazF Sa activity in vitro. A radiolabeled version of this substrate was used to detect the activity of endogenous MazF Sa in S. aureus lysate. This is the first time enzymatic activity of endogenous MazF Sa has been evaluated in the cellular milieu, and the tools described here should facilitate the evaluation of various stressors and assist in the discovery of artificial activators of MazF Sa .
Materials and methods

Materials
Primers and oligonucleotides were synthesized by IDT. Ni 2+ -NTA (nitrilotriacetic acid) resin was obtained from Qiagen. Pepstatin A, leupeptin, aprotinin, phenylmethanesulfonyl fluoride (PMSF), and lysozyme were purchased from Sigma. Restriction enzymes, bovine serum albumin (BSA), a low-range single-stranded RNA (ssRNA) ladder, RNase inhibitor-human placenta, and Escherichia coli strains DH5a and NiCo21(DE3) [23] were purchased from New England Biolabs. Subcloning efficiency DH5a chemically competent E. coli was purchased from Invitrogen. Isopropyl b-D-1-thiogalactopyranoside (IPTG) and kanamycin were purchased from GoldBio. Lysing Matrix B was obtained from MP Biomedicals. [a-32 P]UTP was purchased from PerkinElmer. Sypro Red protein stain was purchased from VWR. Cloning E. coli DH5a and NiCo21(DE3) were used for cloning and protein expression, respectively. The mazEF Sa gene cassette was amplified by PCR using primers mazEF Sa -NcoI-F (5 0 -ACACCCATGGATA-TGTTATCTTTAGTCAAAATAG-3 0 ) and mazEF Sa -XhoI-R (5 0 -CACACTC-GAGATTTTTCTGGTGAGCTAC-3 0 ) from the total DNA of the MRSA strain C2 [17] . The amplicon was inserted into the corresponding restriction sites of pET-28a to create pET-28a-mazEF Sa , which codes for MazEF Sa containing a C-terminal histidine-6 tag on MazF Sa . The mazE Sa antitoxin gene was amplified from the same strain using primers mazE Sa -NdeI-F (5 0 -ACACCATATGTTATCTT TTATCAAATAGAAG-3 0 ) and mazE Sa -XhoI-stop-R (5 0 -ACA-CCTCGAGTCATTCATTCGTTGAATTAGAA-3 0 ) and cloned into pET28a, resulting in pET-28a-mazE Sa , which encodes an N-terminal histidine-6-tagged MazE Sa . The sequence of all clones was determined by DNA sequencing. E. coli carrying the recombinant plasmids was cultured in LB containing 50 lg/ml kanamycin.
Protein expression and purification
To express MazEF Sa (His) 6 , an overnight culture inoculated with a single colony of E. coli NiCo21(DE3) freshly transformed with pET-28a-mazEF Sa was diluted 100-fold into 2 L of LB + kanamycin. The culture was grown at 37°C until the OD 600 reached 0.6 to 0.8, at which point expression was induced with 1 mM IPTG (final concentration) for 4 h at 37°C. Expression of (His) 6 MazE Sa was performed the same except that IPTG was added when the OD 600 reached 0.4 to 0.6. The 2-L cultures were harvested by centrifugation at 4°C (8000g for 500-ml bottles and 10,000g for 50-ml conical tubes) and stored at À20°C.
MazF Sa (His) 6 was purified from the MazEF Sa (His) 6 complex under denaturing conditions. A pellet corresponding to 2 L of culture was thawed in a room temperature water bath for 10 min. The pellet was resuspended in 20 ml of binding buffer (10 mM Tris, 500 mM NaCl, and 10 mM imidazole, pH 7.9) containing 8 M urea and lysed by 30 min of incubation at room temperature with inversion. Cell debris was pelleted by centrifugation at 40,000g at room temperature for 15 min. The clarified lysate was mixed with 1 ml of 1:1 Ni 2+ -NTA resin slurry and batch loaded for 30 min at room temperature with inversion. The slurry was applied to a gravimetric flow column, and the resin was washed with 50 ml of binding buffer containing 8 M urea to fully disrupt the MazE Sa -MazF Sa (-His) 6 complex. On-column refolding of MazF Sa (His) 6 was achieved with seven washes of 10 ml urea/binding buffer, decreasing the concentration of urea by 1 M with each wash. Wash steps containing greater than 4 M urea were performed at room temperature; all subsequent wash steps were performed at 4°C. Refolding was followed with 10-ml washes of binding buffer (containing no urea) and binding buffer containing 60 mM imidazole. MazF Sa (His) 6 was eluted with 5 ml of binding buffer containing 250 mM imidazole. To remove proteins with high intrinsic affinity for Ni
2+
-NTA resin [23] , the eluate was diluted with 5 ml of binding buffer and applied to a 5-ml bed volume of chitin resin (New England Biolabs) followed by washing with 8 ml of binding buffer. The flow-through and wash fractions were combined and concentrated to approximately 1 ml using an Amicon Ultra-15 3-kDa molecular weight cutoff spin concentrator (Millipore) at 4°C. After overnight dialysis in PBS (pH 6.5), the purity and concentration of MazF Sa (His) 6 were assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using 4% to 20% TGX Mini-Protean gels (Bio-Rad). Concentration was determined by densitometry of protein bands in the gel and by BCA (bisinchoninic acid) assay (Pierce) using lysozyme (molecular mass = 14.3 kDa) as the standard for both quantification assays.
(His) 6 MazE Sa was purified under native conditions, and all steps were performed on ice or at 4°C. A pellet corresponding to 2 L of culture was thawed for 5 to 10 min and resuspended in cold binding buffer containing protease inhibitors (2 lg/ml pepstatin A, 1 lg/ml leupeptin, 1 lg/ml aprotinin, and 1 mM PMSF). The cells were lysed by 5 min of sonication with a 1-s pulse at 50% amplitude. The lysate was cleared by 15 min of centrifugation at 40,000g at 4°C, and the supernatant was batch loaded with 0.5 ml of 1:1 Ni 2+ -NTA resin slurry for 30 min at 4°C with inversion. Protease inhibitors were included in the wash and elution buffers. The resin was washed with 20 ml of binding buffer, followed by 25 ml of binding buffer containing 60 mM imidazole. (His) 6 MazE Sa was eluted with 5 ml of binding buffer containing 250 mM imidazole, concentrated to approximately 0.5 ml, and dialyzed against 50 mM sodium phosphate (pH 7.0), 150 mM NaCl, and 1 mM dithiothreitol (DTT). Purity and concentration were assessed using the same method described for MazF Sa (His) 6 .
HPLC analysis of oligonucleotide cleavage products
A 10-ll solution of 16 lM MazF Sa (His) 6 and 32 lM 5 0 -AAGTCrUrACATCAG-3 0 (where ''r'' denotes RNA base) was incubated overnight at 37°C in 10 mM Tris, 500 mM imidazole, and 20% glycerol (pH 7.9). The reaction was diluted with 20 ll of 0.1 M triethylammonium acetate (TEAA, pH 7.0), and 10 ll was analyzed by high-performance liquid chromatography (HPLC) using an Alliance HPLC System (e2965 Separations Module, Waters) with detection at 260 nm (2489 UV/Visible Detector, Waters). The full-length oligonucleotide was separated from the cleavage products on a YMCbasic S5 column (4.6 Â 150 mm, 5 lm, Waters) with a linear gradient of 0.1 M TEAA to 0.05 M TEAA/50% acetonitrile over 25 min. Fractions were analyzed by matrix-assisted laser desorption/ionization (MALDI) mass spectrometry. was added to the wells containing intact substrate. The fluorescence of the wells was measured every 30 s for 45 min using a Criterion Analyst AD (Molecular Devices) with 485 (±15)-nm excitation and 530 (±15)-nm emission filters and a 505-nm cutoff dichroic mirror. The fluorophore was excited with a 1000-W continuous lamp with 10 reads per well. The Z-height was set to 1 nm. A calibration curve of the independently synthesized substrate halves corresponding to the cleavage products, 5
Fluorometric oligonucleotide cleavage assay
0 -6-FAM-AGTCG and ACATCAG-BHQ-3 0 [24] , was constructed to quantify the amount of cleavage product formed based on the relative fluorescence units (RFU) value. Wells containing 0.0625 to 2 lM of the cleavage fragments were prepared alongside the intact oligonucleotide following the same protocol except that PC buffer was added instead of MazF Sa (His) 6 . The calibration curve was constructed by plotting the average RFU measured over the 45-min experiment against the amount of oligonucleotide in the well.
In vitro transcription of an RNA substrate
QuikChange site-directed mutagenesis was performed to modify the MazF Sa cleavage sites in the pET-200-mazEF recombinant plasmid, referred to as pKm6EF [24] . MazF Sa optimal cleavage site 1 was removed by changing TACAT to GGCAT using the primers Site1-QC-F (5 0 -GTTTAACTTTAAGAAGGAGATAGGCATATGCGG GGTTCTCATCATC-3 0 ) and Site1-QC-R (5 0 -GATGATGAGAACCCCGCA-TATGCCTATCTCCTTCTTAAAGTTAAAC-3 0 ), suboptimal cleavage site 2 was removed by changing TACGT to CACAT using Site2-QC-F (5 0 -GGATCCCGGCCACGTTAATGCAGGCGCTCAATC-3 0 ) and Site2-QC-R (5 0 -GATTGAGCGCCTGCATTAACGTGGCCGGGATCC-3 0 ), and the suboptimal cleavage site 3 was optimized by changing from TACGT to TACAT using Site3-QC-F (5 0 -GGTAATGGTAAGCCGA-TACATACCCGATATGG-3 0 ) and Site3-QC-R (5 0 -CCATATCGGGTATG TATCGGCTTACCATTACC-3 0 ). The QuikChange PCR was performed following the guidelines in the QuikChange manual (Stratagene) with annealing temperatures of 58°C for the site 1 and site 2 PCRs and 61°C for the site 3 PCR. The PCR product was purified and digested with DpnI and transformed into subcloning efficiency CaCl 2 -treated E. coli following the manufacturer's instructions except that the cells were heat shocked for 30 s. The transformation was plated on LB containing 50 lg/ml kanamycin. Each mutation was confirmed by sequencing of both strands. The plasmid containing the optimized substrate is referred to as pET-200-1D2D3opt.
To prepare the RNA substrate, the pET-200-1D2D3opt plasmid was digested with HindIII for 3 h at 37°C. The digested plasmid was purified using a QiaPrep spin column (Qiagen) and eluted with 30 ll of diethyl pyrocarbonate (DEPC)-treated water. The digested plasmid (0.5-1 lg) served as the template for in vitro transcription using a T7 High Yield RNA Synthesis Kit (New England Biolabs) according to the manufacturer's instructions. Each transcription reaction was divided into two equal portions and purified according to the RNeasy mini handbook (Qiagen) RNA cleanup protocol using reagents from a Total RNA Kit I (Omega BioTek). RNA was eluted twice with 30 ll of 0.1 mM ethylenediaminetetraacetic acid (EDTA) prepared in DEPC-treated water, and all elution fractions from both columns were pooled. The RNA was quantified by A 260 and checked for integrity by gel electrophoresis on a 5% acrylamide 8-M urea 1Â TBE gel (denaturing gel) run in 1Â TBE (pH 8.3) and post-stained for 15 min with 0.05 lg/ml ethidium bromide.
Synthesis of radiolabeled RNA transcript
Synthesis and purification of the radiolabeled RNA substrate followed the same protocol as described for the unlabeled transcript except that 3.87 lCi of [a- 32 P]UTP was added in addition to the standard amounts of unlabeled nucleoside triphosphates (NTPs).
Gel-based RNA cleavage assay
To assess the cleavage of the 3-site and 1-site substrates, 50 nM MazF Sa (His) 6 was incubated with 50 nM RNA in buffer A (71 mM sodium phosphate, 14.5 mM citrate, 137 mM NaCl, and 2 mM KCl, pH 6.5) at room temperature. To stop the reaction, a 10-ll aliquot was added to 10 ll of SDS-formamide loading dye (87% formamide, 2.75% SDS, 16 mM EDTA, and 0.025% bromophenol blue). Samples were heated to 95°C for at least 5 min prior to analysis on a 3.5% acrylamide denaturing gel and visualized with ethidium bromide.
For the time course assay, the same conditions were followed except that 1 nM MazF Sa (His) 6 and 25 nM RNA were prepared in assay buffer containing 0.01% BSA and the products were separated on 5% acrylamide denaturing gels.
Activity against the radiolabeled substrate was assessed following the same conditions except that 1, 5, or 10 nM MazF Sa (His) 6 was mixed with 100 nM radiolabeled RNA substrate in buffer A containing 0.05% BSA. The products were separated on 5% acrylamide denaturing gels, which were exposed to an Imaging Screen-K (Bio-Rad) for 10 min prior to visualization.
Detection of MazF Sa activity in S. aureus cell lysate
A single colony of MRSA strain NRS26 [17] grown on tryptic soy agar was inoculated into 10 ml of tryptic soy broth (TSB) and grown overnight at 37°C with aeration. A fresh 22-ml culture was seeded with a 100-fold dilution of the overnight culture and grown to an OD 600 of approximately 1.3, at which point 10-ml portions were harvested by centrifugation at 4°C, flash frozen in liquid nitrogen, and stored at À80°C. The pellet was resuspended in 0.3 ml of assay buffer and lysed by vortexing for 4 min with 0.15 g of Lysing Matrix B silica beads (MP Biomedical). The lysate was cleared by 30 s of full-speed centrifugation at room temperature and mixed with 1Â RNase inhibitor. After 7, 15, 35, and 65 min of post-lysis incubation at room temperature, the radiolabeled RNA substrate was added to 100 nM (final concentration) and the samples were heated at 95°C for 1 min. After a 10-min reaction at room temperature with RNA, 10-ll aliquots were quenched with SDS-formamide loading dye, electrophoresed, and imaged as described above. To inhibit endogenous MazF Sa activity in the most active lysate, 200 nM purified (His) 6 MazE Sa was added to lysate 65 min post-lysis and incubated for 10 min prior to the addition of RNA for a 10-min reaction. For negative and positive controls, 100 nM radiolabeled RNA was incubated without or with 10 nM MazF Sa (His) 6 in assay buffer with 0.01% BSA at 95°C for 1 min, followed by room temperature for 1 min.
Results
Design of a fluorogenic RNA-DNA chimeric substrate for kinetic assessment of MazF Sa
MazF Sa optimally cleaves at the sequence U;ACAU in single-stranded RNA and was also shown to cleave the synthetic RNA substrate 5 0 -AAGUCUACAUCAG-3 0 [19] . Based on this substrate, a chimeric DNA-RNA substrate consisting of DNA bases at all positions except for the U and the A surrounding the cleavage site was designed (Fig. 1A) . The DNA bases afford enhanced stability and protection from general ribonucleases. The synthetic chimeric substrate 5 0 -AAGTCrUrACATCAG-3 0 was subjected to cleavage by MazF Sa (His) 6 and analyzed by HPLC. The HPLC trace in Fig. 1B shows the cleavage of approximately 83% of the input chimeric substrate by MazF Sa . MALDI mass spectrometry of fractions confirmed the expected mass of the intact substrate and cleavage products (Fig. 1B) .
A continuous fluorometric assay developed for MazF Ec [24] was modified for kinetic evaluation of MazF Sa . The chimeric substrate from (Fig. 1D) . As has been noted previously, the absolute rate of processing of oligonucleotide substrates by recombinantly expressed and purified toxins is low and thus requires higher concentrations of enzyme than are normally used in standard kinetic assays [24, 25] . Therefore, although the Michaelis-Menten equation was fit to the data to determine an apparent K M and V max , the enzymatic parameters observed for MazF Sa (His) 6 do not follow standard Michaelis-Menten kinetics.
Construction of an RNA substrate for gel-based endoribonuclease activity
Although the fluorogenic substrate is useful for kinetic assessment, MazF Sa cleaves mRNA transcripts as its endogenous substrate. Thus, a method for the analysis of MazF Sa (His) 6 endoribonuclease activity against mRNA was developed. An RNA substrate was generated by in vitro transcription as described in Materials and Methods. The resultant transcript from this template contained three MazF Sa cleavage sites: one preferentially cleaved site (site 1, UACAU), a suboptimal site at which cleavage was not detected (site 2, UACGU), and a second suboptimal site that was cleaved (site 3, UACGU) (Fig. 2 cleavage products by gel electrophoresis (Fig. 2, left) . To improve the resolution of the cleavage products on gels, the original template was engineered by site-directed mutagenesis to remove sites 1 and 2 and optimize site 3, such that the new substrate contained only one cleavage site of the optimal sequence UACAU (Fig. 2, right) . Cleavage of this substrate by MazF Sa resulted in easily distinguishable products (Fig. 2, right) . The sensitivity of this substrate for MazF Sa (His) 6 activity was tested with lower, and perhaps more physiologically relevant, concentrations of MazF Sa . A time course experiment with 1 nM MazF Sa (His) 6 and 25 nM RNA resulted in rapid processing, with approximately 50% cleavage of the substrate in 5 min (Fig. 3) . To our knowledge, this is the most sensitive assay for in vitro assessment of the ribonuclease activity of purified MazF Sa . Furthermore, MazF Sa (His) 6 activity was inhibited by (His) 6 MazE Sa (+E lane, Fig. 3 ), demonstrating the specificity of the cleavage of this substrate.
Radiometric assay for MazF Sa activity
As a prelude to experiments with endogenous MazF Sa from S. aureus lysate, the activity of MazF Sa (His) 6 was assessed with a 32 P-labeled version of the 1-site substrate (from Fig. 2 , right) in a time course experiment. As shown in Fig. 4 , the sensitivity of the assay allows for clear differentiation in the activity of increasing concentrations of MazF Sa . In this experiment, minimal cleavage was detected by 1 nM MazF Sa (His) 6 after 11 min of incubation, moderate processing was observed by 5 nM MazF Sa (His) 6 , and there was significant processing by 10 nM MazF Sa (His) 6 (Fig. 4) .
Detection of endogenous MazF Sa activity in S. aureus cell lysate
The highly sensitive and specific cleavage of the radiolabeled substrate allowed for detection of endogenous MazF Sa activity in S. aureus cell lysate. Lysate was prepared from the S. aureus strain NRS26, in which the mazEF Sa genes and transcript were previously detected [17] . The radiolabeled substrate was added to the lysate 7, 15, 35, and 65 min post-lysis. As shown in Fig. 5 , cleavage of the RNA substrate increased with longer post-lysis incubation times, consistent with MazE Sa being susceptible to proteolysis by endogenous proteases in the lysate, resulting in the release of active MazF Sa . The addition of recombinant (His) 6 MazE Sa to lysate 65 min post-lysis inhibited MazF Sa activity, demonstrating the specificity of the RNA cleavage by endogenous MazF Sa (far right B R Fig.2 . Cleavage of an mRNA transcript substrate by MazF Sa (His) 6 . A transcript was produced as described in Materials and Methods. Incubation of the full-length transcript (1070 nucleotides [nt]) with MazF Sa (His) 6 resulted in the cleavage products shown in the gel and depicted in the schematic below the gel. Left: Cleavage of the 3-site substrate (50 nM) produced four cleavage products within 240-s incubation with MazF Sa (His) 6 (50 nM). The products from MazF Sa (His) 6 cleavage at site 1 (UACAU) and site 3 (UACGU) are depicted below the gel. MazF Sa (His) 6 did not cleave at site 2 (UACGU) within 240 s. Right: cleavage of the 1-site substrate under the same conditions results in two wellseparated products. As shown below the gel, in the 1-site substrate the original cleavage sites 1 and 2 were removed and site 3 was changed to the optimal MazF Sa recognition sequence UACAU. Products were separated by denaturing gel electrophoresis and visualized by ethidium bromide staining. 6 (1 nM) was incubated at room temperature with the 1-site substrate (from Fig. 2,  right, 25 nM) . Activity is detected within 10 s, and greater than 50% processing is achieved by 5 min. To inhibit MazF Sa activity, (His) 6 MazE Sa was incubated with MazF Sa (His) 6 for 15 min prior to reaction with the 1-site mRNA substrate for 60 s (+E lane). Products were separated by denaturing gel electrophoresis and visualized by ethidium bromide staining. lane in Fig. 5 ). This is the first detection of the enzymatic activity of endogenous MazF Sa .
Discussion
TA systems are an ingenious method to maintain a plasmid in a bacterial host. Although their role on the bacterial chromosome is unclear, at the biochemical level type II TA systems operate via the same mechanism whether plasmid or chromosomal; that is, a stable toxin protein is inhibited by a proteolytically labile (and cotranscribed/co-translated) antitoxin protein. Important work has shown that the genes for TA systems are present in a variety of pathogenic bacteria [17, [26] [27] [28] [29] [30] . Fewer publications have reported on the detection of TA transcripts in such bacteria [17, 26, 27] , and fewer still have reported on the detection of the actual TA proteins [18, 21] . Although the presence of the DNA, mRNA, and proteins is clearly informative, it does not tell the whole story, especially for TA systems. Specifically, transcription and translation does not mean that the protein toxin is enzymatically active given the cotranscription and co-translation of the proteic antitoxin.
Here we have described an assay that allows, for the first time, for the detection of MazF Sa enzymatic activity from its endogenous source. The principles applied for the design of this substrate and this assay should be readily transferable to the study of other toxins from TA pairs, especially those that are ribonucleases. There are many questions about the roles of TA systems in basic bacteriology [9, 10, [31] [32] [33] [34] , their function in response to stress [35, 36] , and their potential as novel antibacterial targets [11] [12] [13] [14] 16 ]. The tools described here for the direct detection of endogenous toxin activity should significantly facilitate the answering of those questions. 6 MazE Sa prior to reaction with radiolabeled RNA for 10 min (65+E lane). Products were separated by denaturing gel electrophoresis and visualized by phosphorimaging.
